Viking Global Investors LP Edgewise Therapeutics, Inc. Transaction History
Viking Global Investors LP
- $29.9 Billion
- Q1 2025
A detailed history of Viking Global Investors LP transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Viking Global Investors LP holds 490,035 shares of EWTX stock, worth $6.18 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
490,035
Previous 1,224,986
60.0%
Holding current value
$6.18 Million
Previous $32.7 Million
67.04%
% of portfolio
0.04%
Previous 0.11%
Shares
10 transactions
Others Institutions Holding EWTX
# of Institutions
221Shares Held
105MCall Options Held
2.57MPut Options Held
1.58M-
Orbimed Advisors LLC San Diego, CA15MShares$189 Million10.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$112 Million4.07% of portfolio
-
Perceptive Advisors LLC New York, NY6.55MShares$82.6 Million6.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$77.6 Million1.61% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$75.9 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $797M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...